Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Norepinephrine-Induced Stimulation of Kir4.1/Kir5.1 Is Required for the Activation of NaCl Transporter in Distal Convoluted TubuleXin-Peng Duan, Li Gu, Yu Xiao, et al.
Cancer Research|January 22, 2017
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling AxisSrinivas Nandana, Manisha Tripathi, Peng Duan, et al.
International Journal of Cancer|May 8, 2023
Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trialBao-Dong Qin, Xiao-Dong Jiao, Zhan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2014
miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancerMurali Gururajan, Sajni Josson, Gina Chia-Yi Chu, et al.
Ecology and Evolution|August 30, 2019
Riparian leaf litter decomposition on pond bottom after a retention on floating vegetationYa-Lin Zhang, Wei-Jun Zhang, Jun-Peng Duan, et al.
Biomedicine|May 25, 2019
Applying WCACG modified process is beneficial on reduced door-to-balloon time of acute STEMI patientsQiao-Wen Li, Xiao-Jian Liu, Jin-Hua Li, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 14, 2014
Nonlinear dose-response relationship between radon exposure and the risk of lung cancer: evidence from a meta-analysis of published observational studiesPeng Duan, Chao Quan, Chunhui Hu, et al.
Reproductive Biomedicine Online|May 30, 2020
Potential risks of SARS-CoV-2 infection on reproductive healthRong Li, Tailang Yin, Fang Fang, et al.
Neurobiology of Aging|March 8, 2014
Triggering receptor expressed on myeloid cells 2 variants are rare in Parkinson's disease in a Han Chinese cohortShu-jun Feng, Kun Nie, Rong Gan, et al.
Nature Communications|May 31, 2025
Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trialKe Liu, Bao-Dong Qin, Shi-Qi Chen, et al.
Pageof 31